|
WO2021005129A1
|
|
Combination of ibuprofen and tramadol for relieving pain
|
|
ES2722673A1
|
|
Aqueous ranitidine solution
|
|
RU2649834C1
|
|
Pharmaceutical composition of sildenafil citrate in form of suspension for oral administration
|
|
MX2016003327A
|
|
Pharmaceutical composition of sildenafil citrate in the form of a suspension for oral use.
|
|
ES2604816A1
|
|
Pharmaceutical composition of tramadol for ophthalmic use
|
|
MX2014012158A
|
|
Pharmaceutical composition of ibuprofen and tramadol for ophthalmological use.
|
|
EP3117826A1
|
|
Tobacco substitute product
|
|
BR112014027002A2
|
|
injectable pharmaceutical composition of dexketoprofen and tramadol
|
|
EP2578212A1
|
|
Compound inhibiting activation of the enzyme erk1/2 for use in the treatment of neurogenerative illnesses
|
|
EP2474309A1
|
|
Pharmaceutical composition comprising ibuprofen, tramadol and a basic amino acid, preparation method thereof and use of same
|
|
WO2011113965A1
|
|
Pharmaceutical composition in solid form containing isoflavones, a calcium salt and vitamin d3
|
|
WO2011107617A1
|
|
Liquid ibuprofen/codeine pharmaceutical composition for oral administration, the method for preparation thereof and use thereof
|
|
PL402612A1
|
|
The liquid pharmaceutical composition of ibuprofen and codeine, for oral administration, a method for its preparation and its use
|
|
ES2363395A1
|
|
PHARMACEUTICAL COMPOSITION L�? QUIDA DE RIVASTIGMINA OR ONE OF ITS ADDITION SALES OF �? CIDO FOR ADMINISTRATION BY ORAL.
|
|
ES2362292A1
|
|
ORAL COMPOSITION SOLID PHARMACEUTICAL OR DIETARY SPECIFICALLY INDICATED FOR WOMEN MANAGER.
|
|
ES2353541A1
|
|
COMBINATION OF COSMETIC ACTIVE INGREDIENTS AND COSMETIC COMPOSITION OBTAINED FROM THE SAME, AND ITS USE.
|
|
ES2343294A1
|
|
PHARMACEUTICAL COMPOSITION IN SOLID FORM CONTAINING ISOFLAVONES, A CALCIUM SALT AND VITAMIN D3.
|
|
ES2338972A1
|
|
PHARMACEUTICAL COMPOSITION OF IBUPROFEN AND CODEINA LIQUID FOR ADMINISTRATION BY ORAL ROUTE, ITS PROCEDURE FOR PREPARATION AND USE OF THE SAME.
|
|
ES2341517A1
|
|
USE OF AN INHIBITOR COMPOUND OF THE ACTIVATION OF THE ERK 1/2 ENZYME IN THE TREATMENT OF NEURODEGENERATIVE DISEASES.
|
|
ES2338194A1
|
|
USE OF REPLACED PHENYLETHYLAMINS AS INHIBITORS OF THE ACTIVATION OF THE ERK 1/2 ENZYME IN THE TREATMENT OF NEURODEGENERATIVE DISEASES.
|
